ArticleMedicine2016

Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study.

Yu-Cheng Hsieh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.